Page 5 - Precision Flow News Today

Wall Street analysts predict that Vapotherm, Inc. (NYSE:VAPO – Get Rating) will post sales of $19.34 million for the current fiscal quarter, Zacks Investment Research reports. Two analysts have made estimates for Vapotherm’s earnings, with the highest sales estimate coming in at $19.98 million and the lowest estimate coming in at $18.70 million. Vapotherm posted […]

Vapotherm (NYSE:VAPO – Get Rating) and Asensus Surgical (NYSE:ASXC – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, risk, profitability and institutional ownership. Valuation and Earnings This table compares Vapotherm and Asensus Surgical’s […]

Vapotherm (NYSE:VAPO – Get Rating) had its target price lowered by Piper Sandler from $5.00 to $2.50 in a research report released on Thursday morning, The Fly reports. The brokerage currently has an underweight rating on the stock. VAPO has been the topic of a number of other reports. Zacks Investment Research downgraded shares of […]

Vapotherm (NYSE:VAPO – Get Rating) had its price objective reduced by equities researchers at Piper Sandler from $5.00 to $2.50 in a research note issued on Thursday, The Fly reports. Piper Sandler’s price target points to a potential downside of 15.25% from the stock’s previous close. VAPO has been the subject of a number of […]

Vapotherm, Inc. (NYSE:VAPO – Get Rating) CFO John Landry bought 5,000 shares of the company’s stock in a transaction on Tuesday, May 24th. The shares were purchased at an average cost of $2.90 per share, for a total transaction of $14,500.00. Following the transaction, the chief financial officer now owns 128,074 shares in the company, […]

Vapotherm (NYSE:VAPO – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Tuesday, Zacks.com reports. According to Zacks, “Vapotherm Inc. is a medical technology company. It designs and develops respiratory devices for the treatment of chronic lung and acute breathing disorders. The Company […]

Zacks Investment Research upgraded shares of Vapotherm (NYSE:VAPO – Get Rating) from a hold rating to a buy rating in a research report report published on Wednesday, Zacks.com reports. They currently have $5.25 price target on the stock. According to Zacks, “Vapotherm Inc. is a medical technology company. It designs and develops respiratory devices for […]

Vapotherm (NYSE:VAPO – Get Rating) is set to post its quarterly earnings results after the market closes on Wednesday, May 4th. Analysts expect the company to announce earnings of ($0.63) per share for the quarter. Vapotherm has set its FY 2022 guidance at EPS.Persons that are interested in participating in the company’s earnings conference call […]

A number of firms have modified their ratings and price targets on shares of Vapotherm (NYSE: VAPO) recently: 4/23/2022 – Vapotherm was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “hold” rating. According to Zacks, “Vapotherm Inc. is a medical technology company. It designs and develops respiratory devices for the […]

Vapotherm (NYSE:VAPO – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued to investors on Saturday, Zacks.com reports. According to Zacks, “Vapotherm Inc. is a medical technology company. It designs and develops respiratory devices for the treatment of chronic lung and acute breathing […]